Andrea Pfeifer

In 2003, Dr Andrea Pfeifer co-founded AC Immune SA, a Swiss-based biopharmaceutical company that aims to become a global leader in precision medicine for neurodegenerative diseases. She has since held the position of CEO and has served as a member of the Board of Directors since the company's IPO in 2016. Under her leadership, AC Immune has built a reputation for outstanding science and as a globally recognised pipeline with six product candidates currently in clinical trials. Dr Pfeifer holds a PhD in toxicology as well as cancer research, has qualified as a private lecturer at UNIL and is an honorary professor at EPFL.